Synopsis: Lincoln Pharmaceuticals, Avalon Technologies, and Skipper Limited are in focus after issuing strong FY26 revenue growth guidance of up to 40%, signalling confidence in business momentum and expansion plans.
Several companies have issued upbeat outlooks for FY26, guiding for revenue growth of up to 40 percent as demand improves across sectors. Such aggressive targets signal strong order pipelines, capacity expansion, and improved execution visibility. Investors are tracking these stocks closely, as high growth guidance often reflects management confidence and potential earnings momentum. Here are a few stocks with revenue guidance of up to 40 percent growth for FY26
Lincoln Pharmaceuticals Ltd
With a market capitalization of Rs. 1,297.13 crore, the shares of Lincoln Pharmaceuticals Limited closed at Rs. 647.60 per equity share, rising nearly 5.57 percent from its previous day’s close price of Rs. 613.45.
Lincoln Pharmaceuticals Limited is targeting a revenue of Rs. 1,000 crore within the next three years, driven by business expansion into high-value product lines and entry into new markets. This goal is part of a broader strategy to achieve a 15-18 percent annual growth rate, driven by strong performance in the cardiac, diabetic, dermatology, and ENT segments.
Lincoln Pharmaceuticals Limited was established in 1979 and is an Indian pharmaceutical company that manufactures and markets a wide range of formulations, such as tablets, capsules, injections, and ointments, across multiple therapeutic areas for the healthcare market.
Coming into financial highlights, Lincoln Pharmaceuticals Limited’s revenue has increased from Rs. 147 crore in Q3 FY25 to Rs. 166 crore in Q3 FY26, which has grown by 12.93 percent. The net profit has also grown by 38.10 percent from Rs. 21 crore in Q3 FY25 to Rs. 29 crore in Q3 FY26.
Avalon Technologies Limited
With a market capitalization of Rs. 7,039.73 crore, the shares of Avalon Technologies Limited closed at Rs. 1054.50 per equity share, down nearly 2.91 percent from its previous day’s close price of Rs. 1086.05.
Avalon Technologies Limited has revised its FY26 revenue growth guidance upward to around 40 percent, compared with its earlier outlook of 28-30 percent, reflecting stronger business momentum. As of December 31, 2025, the company’s order book rose 26.5 percent YoY to Rs. 2,016 crore, with an average execution timeline of about 14 months, supporting revenue visibility.
Avalon Technologies Limited was founded in 1999 and is a technology and manufacturing company that designs, develops, and manufactures electronic systems, printed circuit boards (PCBs), cable harnesses, and related components for sectors like automotive, aerospace, industrial and communications.
Coming into financial highlights, Avalon Technologies Limited’s revenue has increased from Rs. 281 crore in Q3 FY25 to Rs. 418 crore in Q3 FY26, which has grown by 48.75 percent. The net profit has also grown by 37.50 percent from Rs. 24 crore in Q3 FY25 to Rs. 33 crore in Q3 FY26.
Skipper Limited
With a market capitalization of Rs. 4,221.89 crore, the shares of Skipper Limited closed at Rs. 374 per equity share, down nearly 1.88 percent from its previous day’s close price of Rs. 381.15.
Skipper Limited has guided for 20-25 percent annual revenue growth over the next three years, supported by a planned Rs. 800 crore capex over four years. The company expects EBITDA margins of 10-10.5 percent, with gradual improvement projected year-on-year over the next two to three years.
Skipper Limited was established in 1981 and is an engineering and infrastructure company that manufactures power transmission and distribution products, including towers, poles, conductors, and PVC pipes and fittings. It also provides engineering, procurement and construction (EPC) services for infrastructure projects.
Coming into financial highlights, Skipper Limited’s revenue has increased from Rs. 1,135 crore in Q3 FY25 to Rs. 1,371 crore in Q3 FY26, which has grown by 20.79 percent. The net profit has also grown by 47.22 percent from Rs. 36 crore in Q3 FY25 to Rs. 53 crore in Q3 FY26.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
